Using KG1 and U937 AML cell lines, two models with distinct ABCB1 activity and LSC compartment proportions, we observed opposite responses to Ara-C treatment with regard to ORAI1 expression and SOCE modulation. The gene discussed is ABCB1; the disease is acute myeloid leukemia.